Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2006-09-08
  Clinical Trial Update: Acupuncture For Pancreatic Cancer Pain [Phase 3]

  Phase 3 trial evaluating acupuncture for pancreatic cancer-related pain has completed.

• CLINICAL_TRIALS trial_result · 2006-07-28
  Clinical Trial Update: Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer [Phase 1, Phase 2]

  An early-phase trial investigating a survivin peptide vaccine in patients with advanced melanoma, pancreatic cancer, colon cancer, and cervi…

• CLINICAL_TRIALS trial_result · 2006-07-19
  Clinical Trial Update: A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. [Phase 3]

  A Phase 3 trial compared ALIMTA (pemetrexed) plus GEMZAR (gemcitabine) versus GEMZAR alone in unresectable or metastatic pancreatic cancer a…

• CLINICAL_TRIALS trial_result · 2006-06-29
  Clinical Trial Update: 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer [Phase 2]

  Clinical trial update on a Phase 2 study evaluating 32P BioSilicon in combination with Gemcitabine for pancreatic cancer.

• FDA trial_result ·
  FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug

  FDA issued a safe-to-proceed letter allowing expanded access treatment for an investigational pancreatic cancer drug, daraxonrasib, by Revol…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.